Glucose-stimulated hormone release in rats bearing streptozotocin/nicotinamide-induced islet adenomas: Evidence for slow and fast responders

G. Eric Bauer, Padmakar K. Dixit, Robert L. Sorenson, Jane D. Wobken

Research output: Contribution to journalArticlepeer-review

Abstract

Rats injected with streptozotocin and nicotinamide developed grossly visible islet cell tumors of the pancreas. During i.v. glucose tolerance tests, two populations of tumor-bearing rats were identified: Fast responders exhibited significantly lower plasma glucose and markedly elevated plasma immunoreactive insulin (IRI) levels relative to those of the controls. In slow responders, the plasma glucose level was significantly elevated up to 2 h after glucose injection, and the plasma IRI level was lower than that of the controls. During in vitro perfusions with glucose at 300 mg/dl (16.7 mM), tumor-bearing pancreata of fast responders released elevated levels of IRI and immunoreactive somatostatin (IRS); after tumor removal, glucose-stimulated release of these hormones returned to control levels. However, during similar perfusions of pancreata from slow responders, the IRI and IRS release did not decrease after tumor removal, suggesting that the nontumorous pancreatic islets rather than the gross tumors of the slow-responder group were the source of the glucose-stimulated hormone release. These studies demonstrate that gross tumors in the two responder subgroups differ in their glucose-stimulated hor-mone release.

Original languageEnglish (US)
Pages (from-to)464-471
Number of pages8
JournalPancreas
Volume4
Issue number4
DOIs
StatePublished - Aug 1989

Keywords

  • Glucose tol-erance
  • Insulin release
  • Islet adenomas
  • Pancreatic perfusion
  • Somatostatin release
  • Streptozotocin

Fingerprint Dive into the research topics of 'Glucose-stimulated hormone release in rats bearing streptozotocin/nicotinamide-induced islet adenomas: Evidence for slow and fast responders'. Together they form a unique fingerprint.

Cite this